Selected research
Industry Growth & Trends
Global Metamizole Sodium Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Metamizole Sodium Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Metamizole Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Metamizole Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metamizole Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metamizole Sodium Injection include Teva Pharmaceutical, Sanofi, Novartis, WAMIN, Taj Life Sciences, Reyoung Pharma, Naman Pharma Drugs, MSD and Montage Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Metamizole Sodium Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Metamizole Sodium Injection market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metamizole Sodium Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metamizole Sodium Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Metamizole Sodium Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Metamizole Sodium Injection Market by Company
Teva Pharmaceutical
Sanofi
Novartis
WAMIN
Taj Life Sciences
Reyoung Pharma
Naman Pharma Drugs
MSD
Montage Laboratories
Krosyl Pharmaceutical
Drag Pharma
Centurion Healthcare
Bhumi Pharmaceuticals
AdvaCare Pharma
Metamizole Sodium Injection Segment by Type
500mg/1ml
1000mg/2 ml
Metamizole Sodium Injection Segment by Application
Hospital
Research Institute
Metamizole Sodium Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metamizole Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metamizole Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metamizole Sodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metamizole Sodium Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Metamizole Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg/1ml
- 1000mg/2 ml
Applications
- Hospital
- Research Institute
Companies covered
- Teva Pharmaceutical
- Sanofi
- Novartis
- WAMIN
- Taj Life Sciences
- Reyoung Pharma
- Naman Pharma Drugs
- MSD
- Montage Laboratories
- Krosyl Pharmaceutical
- Drag Pharma
- Centurion Healthcare
- Bhumi Pharmaceuticals
- AdvaCare Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metamizole Sodium Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metamizole Sodium Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Metamizole Sodium Injection Market by Type
- 1.3.1 500mg/1ml
- 1.3.2 1000mg/2 ml
- 1.4 Global Metamizole Sodium Injection Market Size by Type
- 1.4.1 Global Metamizole Sodium Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Metamizole Sodium Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Metamizole Sodium Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Metamizole Sodium Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Metamizole Sodium Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Metamizole Sodium Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Metamizole Sodium Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Metamizole Sodium Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Metamizole Sodium Injection Industry Trends
- 2.2 Metamizole Sodium Injection Industry Drivers
- 2.3 Metamizole Sodium Injection Industry Opportunities and Challenges
- 2.4 Metamizole Sodium Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Metamizole Sodium Injection Revenue (2021-2026)
- 3.2 Global Top Players by Metamizole Sodium Injection Sales (2021-2026)
- 3.3 Global Top Players by Metamizole Sodium Injection Price (2021-2026)
- 3.4 Global Metamizole Sodium Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metamizole Sodium Injection Major Company Production Sites & Headquarters
- 3.6 Global Metamizole Sodium Injection Company, Product Type & Application
- 3.7 Global Metamizole Sodium Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metamizole Sodium Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metamizole Sodium Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Metamizole Sodium Injection Tier 1, Tier 2, and Tier 3
4 Metamizole Sodium Injection Regional Status and Outlook
- 4.1 Global Metamizole Sodium Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Metamizole Sodium Injection Historic Market Size by Region
- 4.2.1 Global Metamizole Sodium Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Metamizole Sodium Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Metamizole Sodium Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Metamizole Sodium Injection Forecasted Market Size by Region
- 4.3.1 Global Metamizole Sodium Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Metamizole Sodium Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Metamizole Sodium Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metamizole Sodium Injection by Application
- 5.1 Metamizole Sodium Injection Market by Application
- 5.1.1 Hospital
- 5.1.2 Research Institute
- 5.2 Global Metamizole Sodium Injection Market Size by Application
- 5.2.1 Global Metamizole Sodium Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Metamizole Sodium Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Metamizole Sodium Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Metamizole Sodium Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Metamizole Sodium Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Metamizole Sodium Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Metamizole Sodium Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Metamizole Sodium Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceutical
- 6.1.1 Teva Pharmaceutical Company Information
- 6.1.2 Teva Pharmaceutical Business Overview
- 6.1.3 Teva Pharmaceutical Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceutical Metamizole Sodium Injection Product Portfolio
- 6.1.5 Teva Pharmaceutical Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sanofi Metamizole Sodium Injection Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Metamizole Sodium Injection Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 WAMIN
- 6.4.1 WAMIN Company Information
- 6.4.2 WAMIN Business Overview
- 6.4.3 WAMIN Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 WAMIN Metamizole Sodium Injection Product Portfolio
- 6.4.5 WAMIN Recent Developments
- 6.5 Taj Life Sciences
- 6.5.1 Taj Life Sciences Company Information
- 6.5.2 Taj Life Sciences Business Overview
- 6.5.3 Taj Life Sciences Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taj Life Sciences Metamizole Sodium Injection Product Portfolio
- 6.5.5 Taj Life Sciences Recent Developments
- 6.6 Reyoung Pharma
- 6.6.1 Reyoung Pharma Company Information
- 6.6.2 Reyoung Pharma Business Overview
- 6.6.3 Reyoung Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Reyoung Pharma Metamizole Sodium Injection Product Portfolio
- 6.6.5 Reyoung Pharma Recent Developments
- 6.7 Naman Pharma Drugs
- 6.7.1 Naman Pharma Drugs Company Information
- 6.7.2 Naman Pharma Drugs Business Overview
- 6.7.3 Naman Pharma Drugs Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Naman Pharma Drugs Metamizole Sodium Injection Product Portfolio
- 6.7.5 Naman Pharma Drugs Recent Developments
- 6.8 MSD
- 6.8.1 MSD Company Information
- 6.8.2 MSD Business Overview
- 6.8.3 MSD Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 MSD Metamizole Sodium Injection Product Portfolio
- 6.8.5 MSD Recent Developments
- 6.9 Montage Laboratories
- 6.9.1 Montage Laboratories Company Information
- 6.9.2 Montage Laboratories Business Overview
- 6.9.3 Montage Laboratories Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Montage Laboratories Metamizole Sodium Injection Product Portfolio
- 6.9.5 Montage Laboratories Recent Developments
- 6.10 Krosyl Pharmaceutical
- 6.10.1 Krosyl Pharmaceutical Company Information
- 6.10.2 Krosyl Pharmaceutical Business Overview
- 6.10.3 Krosyl Pharmaceutical Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Krosyl Pharmaceutical Metamizole Sodium Injection Product Portfolio
- 6.10.5 Krosyl Pharmaceutical Recent Developments
- 6.11 Drag Pharma
- 6.11.1 Drag Pharma Company Information
- 6.11.2 Drag Pharma Business Overview
- 6.11.3 Drag Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Drag Pharma Metamizole Sodium Injection Product Portfolio
- 6.11.5 Drag Pharma Recent Developments
- 6.12 Centurion Healthcare
- 6.12.1 Centurion Healthcare Company Information
- 6.12.2 Centurion Healthcare Business Overview
- 6.12.3 Centurion Healthcare Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Centurion Healthcare Metamizole Sodium Injection Product Portfolio
- 6.12.5 Centurion Healthcare Recent Developments
- 6.13 Bhumi Pharmaceuticals
- 6.13.1 Bhumi Pharmaceuticals Company Information
- 6.13.2 Bhumi Pharmaceuticals Business Overview
- 6.13.3 Bhumi Pharmaceuticals Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Bhumi Pharmaceuticals Metamizole Sodium Injection Product Portfolio
- 6.13.5 Bhumi Pharmaceuticals Recent Developments
- 6.14 AdvaCare Pharma
- 6.14.1 AdvaCare Pharma Company Information
- 6.14.2 AdvaCare Pharma Business Overview
- 6.14.3 AdvaCare Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 AdvaCare Pharma Metamizole Sodium Injection Product Portfolio
- 6.14.5 AdvaCare Pharma Recent Developments
7 North America by Country
- 7.1 North America Metamizole Sodium Injection Sales by Country
- 7.1.1 North America Metamizole Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Metamizole Sodium Injection Sales by Country (2021-2026)
- 7.1.3 North America Metamizole Sodium Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Metamizole Sodium Injection Market Size by Country
- 7.2.1 North America Metamizole Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Metamizole Sodium Injection Market Size by Country (2021-2026)
- 7.2.3 North America Metamizole Sodium Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Metamizole Sodium Injection Sales by Country
- 8.1.1 Europe Metamizole Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Metamizole Sodium Injection Sales by Country (2021-2026)
- 8.1.3 Europe Metamizole Sodium Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Metamizole Sodium Injection Market Size by Country
- 8.2.1 Europe Metamizole Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Metamizole Sodium Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Metamizole Sodium Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Metamizole Sodium Injection Sales by Country
- 9.1.1 Asia-Pacific Metamizole Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Metamizole Sodium Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Metamizole Sodium Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Metamizole Sodium Injection Market Size by Country
- 9.2.1 Asia-Pacific Metamizole Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Metamizole Sodium Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Metamizole Sodium Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Metamizole Sodium Injection Sales by Country
- 10.1.1 South America Metamizole Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Metamizole Sodium Injection Sales by Country (2021-2026)
- 10.1.3 South America Metamizole Sodium Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Metamizole Sodium Injection Market Size by Country
- 10.2.1 South America Metamizole Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Metamizole Sodium Injection Market Size by Country (2021-2026)
- 10.2.3 South America Metamizole Sodium Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Metamizole Sodium Injection Sales by Country
- 11.1.1 Middle East and Africa Metamizole Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Metamizole Sodium Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Metamizole Sodium Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Metamizole Sodium Injection Market Size by Country
- 11.2.1 Middle East and Africa Metamizole Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Metamizole Sodium Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Metamizole Sodium Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Metamizole Sodium Injection Value Chain Analysis
- 12.1.1 Metamizole Sodium Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Metamizole Sodium Injection Production Mode & Process
- 12.2 Metamizole Sodium Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Metamizole Sodium Injection Distributors
- 12.2.3 Metamizole Sodium Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst